Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

McGill University

$399,700.00

Structural and Function Studies of Nonribosomal Peptide Synthetases

EF 2009-10

Résumé
Many of the drugs and medicines that we rely on today are so-called natural products, made by the earth's flora and fauna. One important class of these compounds is made by fungi and bacteria using massive enzymes called nonribosomal peptide synthetases (NRPS). NRPSs synthesize all sorts of antibiotics, which can kill dangerous fungi and bacteria, as well as compounds that can help us fight off viral infections and cancers. For example, these compounds include viomycin, an antibiotic used for the treatment of multidrug-resistant tuberculosis, cyclosporin, which has been widely used as an immunosuppressant in organ transplants and can inhibit hepatitis virus C replication, and penicillin, the famous antibiotic. The goal of this research is to expand our knowledge of NRPSs and the mechanisms they employ to synthesize important drugs. I will use biochemistry and biophysics, including techniques known as X-ray crystallography and cryo-electron microscopy, to capture three-dimensional pictures of an NRPS at different points in the process of making these antibiotics. I will study several NRPSs, including the penicillin synthesizing enzyme and the cyclosporin synthesizing enzyme, but the results of the work will be applicable to all NRPSs. The subjects addressed will range from elucidating the precise details of how building blocks are chemically assembled into the antibiotics, to understanding the large-scale rearrangements these enzymes need to perform to these drugs. NRPSs hold a vast potential to produce new drugs. Because NRPSs are divided into segments, with each segment adding one building block to the drug, we can switch around the order and specific type of segment to produce variants of the drug. My studies can help us learn how best to re-arrange NRPS segments to make millions of new compounds. Among these compounds could be important drugs to fight antibiotic resistant bacteria, viruses and cancer.
Programme
Operating Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
199223
Name
Schmeing Thomas Martin
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Structural and Function Studies of Nonribosomal Peptide Synthetases
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$399,700
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Antibiotics; Biochemistry; Cancer Drugs; Electron Microscopy; Enzymes; Microbiology; Molecular Machines; Protein Engineering; Reaction Mechanisms; X-Ray Crystallography
Abstract
Many of the drugs and medicines that we rely on today are so-called natural products, made by the earth's flora and fauna. One important class of these compounds is made by fungi and bacteria using massive enzymes called nonribosomal peptide synthetases (NRPS). NRPSs synthesize all sorts of antibiotics, which can kill dangerous fungi and bacteria, as well as compounds that can help us fight off viral infections and cancers. For example, these compounds include viomycin, an antibiotic used for the treatment of multidrug-resistant tuberculosis, cyclosporin, which has been widely used as an immunosuppressant in organ transplants and can inhibit hepatitis virus C replication, and penicillin, the famous antibiotic. The goal of this research is to expand our knowledge of NRPSs and the mechanisms they employ to synthesize important drugs. I will use biochemistry and biophysics, including techniques known as X-ray crystallography and cryo-electron microscopy, to capture three-dimensional pictures of an NRPS at different points in the process of making these antibiotics. I will study several NRPSs, including the penicillin synthesizing enzyme and the cyclosporin synthesizing enzyme, but the results of the work will be applicable to all NRPSs. The subjects addressed will range from elucidating the precise details of how building blocks are chemically assembled into the antibiotics, to understanding the large-scale rearrangements these enzymes need to perform to these drugs. NRPSs hold a vast potential to produce new drugs. Because NRPSs are divided into segments, with each segment adding one building block to the drug, we can switch around the order and specific type of segment to produce variants of the drug. My studies can help us learn how best to re-arrange NRPS segments to make millions of new compounds. Among these compounds could be important drugs to fight antibiotic resistant bacteria, viruses and cancer.
Competitiondate
201003
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Schmeing, Thomas Martin
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $399,700~ $0~